Current Perspectives Regarding Stem Cell-based Therapy for Ischemic Stroke

Author(s): Kyeong-Ah Kwak, Ho-Beom Kwon, Joo Won Lee, Young-Seok Park*

Journal Name: Current Pharmaceutical Design

Volume 24 , Issue 28 , 2018

Become EABM
Become Reviewer
Call for Editor


Stroke is a leading cause of death and disability worldwide. Conventional treatment has a limitation of very narrow therapeutic time window and its devastating nature necessitate a novel regenerative approach. Transplanted stem cells resulted in functional recovery through multiple mechanisms including neuroprotection, neurogenesis, angiogenesis, immunomodulation, and anti-inflammatory effects. Despite the promising features shown in experimental studies, results from clinical trials are inconclusive from the perspective of efficacy. The present review presents a synopsis of stem cell research on ischemic stroke treatment according to cell type. Clinical trials to the present are briefly summarized. Finally, the hurdles and issues to be solved are discussed for clinical application.

Keywords: Stroke, cell-based therapy, clinical trials, stem cells, angiogenesis, immunomodulation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 07 December, 2018
Page: [3332 - 3340]
Pages: 9
DOI: 10.2174/1381612824666180604111806
Price: $65

Article Metrics

PDF: 46
HTML: 13